Profile
ACRX ZTS HLN TAK TEVA VTRS
Company Name AcelRx Pharmaceuticals, Inc. Zoetis Inc. Haleon plc Takeda Pharmaceutical Company Limited Teva Pharmaceutical Industries Limited Viatris Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap $14.58M $79.84B $43.93B $42.42B $19.40B $15.82B
Employees 0.02K 14.10K 25.41K 49.28K 37.00K 32.00K
CEO Mr. Vincent J. Angotti Ms. Kristin C. Peck Mr. Brian James McNamara Mr. Christophe Weber Mr. Richard D. Francis Mr. Scott Andrew Smith Ph.D.
Ratings
ACRX ZTS HLN TAK TEVA VTRS
Quant Rating Score 3 3 3 3 1 3
Quant Rating Neutral Neutral Neutral Neutral Strong Sell Neutral
Trading
ACRX ZTS HLN TAK TEVA VTRS
Last Close $0.86 $176.96 $9.65 $13.38 $17.12 $13.37
High 52 $0.86 $199.94 $10.69 $15.08 $18.96 $13.53
Low 52 $0.74 $145.54 $8.01 $12.6 $10.44 $10.05
Price vs. 52 Week High 0 % -11.49 % -9.73 % -11.27 % -9.7 % -1.18 %
Price vs. 52 Week Low 16.22 % 21.59 % 20.47 % 6.19 % 63.98 % 33.03 %
Total Return
ACRX ZTS HLN TAK TEVA VTRS
1 Month Return 0 % -6.37 % -2.53 % -3.46 % -7.01 % 15.76 %
3 Month Return 0 % -2.18 % -2.53 % -11.27 % -7.76 % 13.69 %
6 Month Return 0 % 3.55 % 14.07 % 2.76 % 2.15 % 26.97 %
9 Month Return 0 % -10.27 % 14.74 % -8.48 % 32.82 % -1.18 %
YTD Return 17.01 % -10.34 % 17.25 % -6.24 % 63.98 % 23.45 %
1 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ACRX ZTS HLN TAK TEVA VTRS
Dividend Yield Percentage (TTM) - 0.98 % 1.62 % 4.67 % - 3.62 %
Dividend Paid and Capex Coverage Ration (TTM) - 2.1 % - 1.34 % 5.06 % 2.39 %
Dividend Per Share (TTM) - 1.73 % 0.06 % 192 % - 0.48 %
Payout Ratio (TTM) - 31.44 % - 101.62 % - -65.15 %
Growth
ACRX ZTS HLN TAK TEVA VTRS
Asset Growth -57.05 % -4.28 % -2.18 % 8.25 % -1.2 % -4.67 %
Gross Profit Growth 179.39 % 3.7 % 5.85 % -16.6 % 9.64 % -0.9 %
Revenue Growth -63.24 % 5.74 % 4.09 % 5.87 % 6.16 % -5.14 %
Revenue 3 Year -100 % 31.98 % 13.9 % 33.13 % -6.92 % -35.32 %
Revenue 5 Year -99.99 % 53.64 % 32.87 % 149.89 % -23.33 % -41.73 %
Revenue 10 Year -100 % 103.1 % 32.87 % 154.38 % -40.82 % -26.57 %
EBIT Growth 53.9 % 6.27 % 37.26 % 7.34 % -84.52 % -52.55 %
Net Income Growth -121.54 % 10.88 % -1.04 % -54.56 % 76.24 % -97.37 %
Net Income 3 Yeari Growth Per Share 99.99 % 47.55 % -8.67 % -61.74 % 86.29 % 104.09 %
Net Income 5 Yeari Growth Per Share 100 % 71.94 % 59.66 % 62.27 % 76.28 % -93.3 %
Net Income 10 Yeari Growth Per Share 99.99 % 404.24 % 59.66 % 36.33 % -133.42 % -97.12 %
Operating Income Growth 53.9 % 6.27 % 37.26 % 7.34 % -84.52 % -52.55 %
Operating Cash Flow Growth (CFG) 38.26 % 23.06 % -16.48 % -34.47 % -13.96 % -5.18 %
Operating 3 Year CFG 99.99 % 14.12 % 22.08 % -36.76 % 10.09 % 13.84 %
Operating 5 Year CFG 99.99 % 37.69 % 118.54 % 139.61 % -48.98 % -48.37 %
Operating 10 Year CFG 99.5 % 274.61 % 118.54 % 335.67 % -67.94 % -16.8 %
EPS Growth -100.01 % 12.64 % - -54.92 % 76.42 % -97.08 %
EPS Diluted Growth -100.01 % 12.92 % - -54.86 % 76.42 % -97.08 %
Book Value Per Share -99.97 % 15.25 % 1.35 % 13.54 % -7.25 % -1.92 %
Share Holder 3 Year Equity Growth Per Share 100.01 % 36.7 % -36.6 % 40.38 % -26.74 % -55.34 %
Share Holder 5 Year Equity Growth Per Share -99.93 % 139.55 % -39.41 % 73.27 % -53.44 % -27.35 %
Share Holder 10 Year Equity Growth Per Share -100 % 476.36 % -39.41 % 197.1 % -74.76 % 128.81 %
Dividend Per Share Growth - 15.15 % -85.58 % 1.95 % - -0.06 %
Dividend 3 Year Growth Per Share -100 % 87.76 % -83.69 % 1.19 % - -
Dividend 5 Year Growth Per Share - 198.29 % -66.42 % 146.94 % -100 % -
Dividend 10 Year Growth Per Share - 665.58 % -66.42 % 103.93 % -100 % -
Debt Growth -100 % -15.91 % -9.43 % 24.67 % -6.53 % -5.93 %
Free Cash Flow Growth 38.69 % 22.25 % -20.06 % -53.54 % -19.19 % -7.35 %
Updated On 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Mar 2024 31 Dec 2023 31 Dec 2023
Profitability
ACRX ZTS HLN TAK TEVA VTRS
Gross Profit Margin TTM -319.46 % 68.87 % 59.91 % 55.23 % 49.87 % 40.26 %
Return on Assets TTM -24.62 % 16.93 % 3.26 % 1.99 % -2.38 % -1.97 %
Return on Equity TTM -39.88 % 47.99 % 6.54 % 4.04 % -14.58 % -4.43 %
Return on Capital Employed TTM -36.97 % 26.64 % 7.22 % 4.18 % 7.66 % -0.71 %
Net Income Per EBT TTM 98.07 % 79.65 % 65.38 % 108.74 % 175.89 % 92.81 %
EBT Per Ebit TTM 80.26 % 90.51 % 82.95 % 52.35 % -26.34 % 359.67 %
EBIT Per Revenue TTM -1967.03 % 36.83 % 17.82 % 11.21 % 12.76 % -1.76 %
Cash Flow To Debt Ratio TTM - 44.8 % - 16.58 % 13 % 13.05 %
Receivables Turnover TTM - 6.49 5.27 6.3 4.85 4.04
Payables Turnover TTM 1.51 7.05 1.25 4.92 3.55 7.23
Inventory Turnover TTM - 1.18 3.09 1.69 2.13 2.2
Fixed Asset Turnover TTM - 259.93 % 604.62 % 240.84 % 278.05 % 561.67 %
Asset Turnover TTM 1.59 % 63.75 % 33.71 % 31.2 % 40.19 % 33.6 %
Operating Cash Flow Per Share TTM -0.49 6.5 - 528.88 2.18 1.93
Free Cash Flow Per Share TTM -0.49 5.1 - 321.24 1.75 1.6
Cash Per Share TTM 79.9 % 378.45 % 5.72 % 54259.65 % 292.94 % 157.41 %
Operating Cash Flow Sales Ratio TTM -2241.35 % 32.18 % - 18.42 % 14.71 % 15.29 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 78.37 % - 60.74 % 80.23 % 83.19 %
Cash Flow Coverage Ratios TTM - 44.8 % - 16.58 % 13 % 13.05 %
Price To Free Cash Flows Ratio TTM -1.76 34.59 - 12.82 9.8 8.27
Price To Operating Cash Flows Ratio TTM -1.74 27.21 - 7.78 7.86 6.88
Price Cash Flow Ratio TTM -1.74 27.21 - 7.78 7.86 6.88
Income Statement (TTM)
ACRX ZTS HLN TAK TEVA VTRS
Revenue $0B $8.54B $11.3B $4263.76B $15.85B $15.43B
Gross Profit $0B $5.83B $6.96B $2321.31B $7.65B $6.44B
Gross Profit Ratio 100% 68.28% 61.6% 54.44% 48.25% 41.74%
EBITDA $-0.02B $3.69B $2.35B $900.33B $4.33B $3.52B
Net Income $-0.01B $2.34B $1.05B $144.07B $-0.56B $0.05B
EPS Diluted - 5.07 0.11 91.16 -0.5 0.05
Balance Sheet (MRQ)
ACRX ZTS HLN TAK TEVA VTRS
Long Term Debt $0B $6.75B $8.95B $5029.93B $18.48B $16.35B
Total Liabilities $0.01B $9.3B $17.33B $7834.79B $35.35B $27.22B
Total Equity $0.01B $4.99B $16.73B $7274.01B $8.13B $20.47B
Total Investments $0B $0.02B $0.07B $683.22B $0.01B $1.33B
Total Debt $0B $6.76B $9.46B $5463.39B $20.15B $18.37B
Total Assets $0.02B $14.29B $34.06B $15108.79B $43.48B $47.69B
Cash Flow Statement (TTM)
ACRX ZTS HLN TAK TEVA VTRS
Net Income $-0.02B $2.34B $1.05B $144.07B $-0.62B $0.05B
Inventory $0B $-0.36B $-0.13B $-115.74B $0B $-0.61B
Dividends Paid $0B $-0.69B $-0.39B $-287.19B $0B $-0.58B
Operating Cash Flow $-0.02B $2.35B $1.72B $640.32B $1.37B $2.8B
Capital Expenditure $-0B $-0.73B $-0.34B $-480.73B $-0.53B $-0.47B
Related Stocks
Ticker Name Price
ACB Aurora Cannabis Inc. 4.34
ACOR Acorda Therapeutics, Inc. 0.661
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AERI Aerie Pharmaceuticals, Inc. 15.25
AGRX Agile Therapeutics, Inc. 1.51
AKAN Akanda Corp. 1.36
ALIM Alimera Sciences, Inc. 5.54
ALVO Alvotech 11.99
ALVOW Alvotech 3
AMPH Amphastar Pharmaceuticals, Inc. 45.46
AMRX Amneal Pharmaceuticals, Inc. 8.39
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 56.91
AQST Aquestive Therapeutics, Inc. 4.56
ASRT Assertio Holdings, Inc. 0.9408
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 11.66
AYTU Aytu BioPharma, Inc. 1.63
BDSI BioDelivery Sciences International, Inc. 5.59
ETFs With Exposure to ACRX
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 296.51
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 131.65
VXF Vanguard Extended Market Index Fund 0 203.42
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 102.82
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 102.8
VQNPX Vanguard Growth and Income Fund 0 70.17
VGIAX Vanguard Quantitative Funds - Vanguard Growth and Income Fund 0 114.54
DFAS Dimensional U.S. Small Cap ETF 0 69.99
VTSAX Vanguard Total Stock Market Index Fund 0 144.38
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 154.29
VITSX Vanguard Total Stock Market Index Fund 0 144.4
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.0000338575 102.35
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 154.3
JKK iShares Morningstar Small-Cap Growth ETF 0 307.42
JKJ iShares Morningstar Small-Cap ETF 0 231.193
VEMPX Vanguard Extended Market Index InstlPlus 0 380.77
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 270.87
Unlock